You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients

Article metrics

Article menu

Download PDFPDF

E-Poster viewings
Ovarian Cancer
IGCS19-0208
292 Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian, fallopian tube or primary peritoneal cancer: our experience in 108 patients
Free

 

Online download statistics by month:

Online download statistics by month: September 2019 to April 2024

AbstractFullPdf
Sep 20191607
Oct 20191907
Nov 20191403
Dec 20191203
Jan 20201603
Feb 20201603
Mar 2020404
Apr 20201602
May 2020600
Jun 20202204
Jul 20201601
Aug 2020603
Sep 20201601
Oct 2020802
Nov 20201401
Dec 20201402
Jan 20211201
Feb 2021200
Mar 2021802
Apr 2021801
May 2021502
Jun 2021001
Aug 2021004
Sep 2021004
Oct 20216015
Nov 20214015
Dec 20212402
Jan 20221405
Feb 20222201
Mar 20221001
Apr 2022605
May 20221008
Jun 2022602
Jul 20221900
Aug 20221406
Sep 20221207
Oct 20221202
Nov 20222105
Dec 2022800
Jan 2023903
Feb 2023600
Mar 2023400
Apr 2023801
May 2023801
Jun 20231002
Jul 20231602
Aug 2023802
Sep 2023400
Oct 20231804
Nov 20231605
Dec 20234500
Jan 20241201
Feb 2024600
Mar 202423022
Apr 20242403
Total6550181